{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T12:24:23Z","timestamp":1795177463005,"version":"4.10.3"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,20]]},"DOI":"10.1097\/cm9.0000000000003799","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:00:46Z","timestamp":1761537646000},"page":"3462-3464","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive management: Paradigm shift of care for psoriasis"],"prefix":"10.1097","volume":"139","author":[{"given":"Yi","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Dermatology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing 102218, China"},{"name":"Photomedicine Laboratory, Institute of Precision Medicine, Tsinghua University, Beijing 102218, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"R1-20261120","article-title":"National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"R2-20261120","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.jaad.2005.04.031","article-title":"A clinician\u2019s paradigm in the treatment of psoriasis","volume":"53","author":"Lebwohl","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R3-20261120","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: What is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br J Dermatol"},{"key":"R4-20261120","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"R5-20261120","article-title":"Psoriatic arthritis: Classification and holistic management","volume":"391","year":"2018","journal-title":"Lancet"},{"key":"R6-20261120","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/jdv.12817","article-title":"PASI90 response: The new standard in therapeutic efficacy for psoriasis","volume":"29","author":"Puig","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R7-20261120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2147\/CLEP.S445120","article-title":"Development and validation of a META-algorithm to identify the indications of use of biological drugs approved for the treatment of immune-mediated inflammatory diseases from claims databases: Insights from the VALORE project","volume":"16","author":"Spini","year":"2024","journal-title":"Clin Epidemiol"},{"key":"R8-20261120","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1468-3083.2010.03574.x","article-title":"Psoriatic disease: Concepts and implications","volume":"24","author":"Scarpa","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R9-20261120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R10-20261120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaad.2016.07.065","article-title":"Psoriasis and comorbid diseases: Implications for management","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R11-20261120","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/bjd.18333","article-title":"Psoriasis treat to target: Defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)","volume":"182","author":"Mahil","year":"2020","journal-title":"Br J Dermatol"},{"key":"R12-20261120","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaad.2021.11.004","article-title":"Consistent safety profile with up to 5\u00a0years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis","volume":"86","author":"Blauvelt","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R13-20261120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/09546634.2018.1437739","article-title":"Psoriasis in the perspective of predictive, preventive participatory and personalized medicine","volume":"29","author":"Van De Kerkhof","year":"2018","journal-title":"J Dermatol Treat"},{"key":"R15-20261120","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1111\/jdv.13248","article-title":"A patient-centred approach to biological treatment decision making for psoriasis: An expert consensus","volume":"29","author":"Strohal","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R16-20261120","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/jdv.16205","article-title":"Drug survival in patients with psoriasis is associated with the availability of biologic medications","volume":"34","author":"Shalom","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R17-20261120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/bjd\/ljac128","article-title":"Access to psoriasis treatment in Brazil and Chile: A cross-sectional multicentre Global Healthcare Study on Psoriasis","volume":"188","author":"Maul","year":"2023","journal-title":"Br J Dermatol"},{"key":"R18-20261120","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.3390\/ijms241713313","article-title":"Challenges and future trends in the treatment of psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R19-20261120","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/CM9.0000000000001588","article-title":"A multidisciplinary team for the diagnosis and management of psoriatic arthritis","volume":"134","author":"Zheng","year":"2021","journal-title":"Chin Med J"},{"key":"R20-20261120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/jdv.13452","article-title":"Barriers to guideline-compliant psoriasis care: Analyses and concepts","volume":"30","author":"Eissing","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R21-20261120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/jdv.15277","article-title":"Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response","volume":"33","author":"Sawyer","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R22-20261120","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaad.2023.06.058","article-title":"Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry","volume":"89","author":"Jin","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R23-20261120","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jaad.2007.07.023","article-title":"Association of patient-reported psoriasis severity with income and employment","volume":"57","author":"Horn","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R24-20261120","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/jcm14041312","article-title":"Therapeutic advancements in psoriasis and psoriatic arthritis","volume":"14","author":"Yi","year":"2025","journal-title":"J Clin Med"},{"key":"R25-20261120","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/exd.14938","article-title":"Artificial intelligence in psoriasis: Where we are and where we are going","volume":"32","author":"Liu","year":"2023","journal-title":"Exp Dermatol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000003799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T12:00:19Z","timestamp":1795176019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000003799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":24,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003799","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"2025-04-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}